Article    Table of Contents                    Full Text of this article Free    Figures/Tables List    Related articles in Annals  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Cherubin, C. E.    Sapira, J. D.    Related Articles in PubMed    PubMed Citation    PubMed

REVIEW

The Medical Complications of Drug Addiction and the Medical Assessment of the Intravenous Drug User: 25 Years Later

Charles E. Cherubin and Joseph D. Sapira

15 November 1993 | Volume 119 Issue 10 | Pages 1017-1028

Purpose: To review changes in the medical complications of drug abuse that have occurred since the authors reviewed them 25 years ago.

Data Source: Manual search of the internal medicine and subspecialty literature of the past three decades that was selected by the authors.

Study Selection: Selected studies were of three types—baseline studies for the period ending in 1968, studies after 1968 that emphasized changes from baseline, and studies after 1968 that emphasized change (or the absence of change) and the manner in which clinicians conceptualized problems.

Data Extraction: We extracted data that showed changes in the diseases, the appearance of new diseases, or the disappearance of formerly common diseases.

Results of Data Synthesis: The diseases complicating drug abuse are now more widely disseminated than they were in the last 25 years. Some former "diseases of addiction" such as tetanus and malaria are now rare. Diseases (such as human immunodeficiency virus infection) not known to exist or rare 25 years ago now occur frequently. The drugs of abuse have also changed; for example, cocaine is now much more common.

Conclusions: Treating the acute medical problems (mostly infectious diseases) in poor, undereducated, and often noncompliant intravenous drug users is far more complex than previously described. Although some features have remained constant, the emergence of human immunodeficiency virus infection and changes in patterns of drug use have radically altered patient management.

Author and Article Information

From the Veterans Affairs Medical Center, Wilkes-Barre, Pennsylvania; the Veterans Affairs Medical Center, St. Louis, Missouri.

Related articles in Annals:

Editorials
Illicit Drug Use Revisited: What a Long, Strange Trip It's Been
Peter A. Selwyn

Annals 1993 119: 1044-1046. [Full Text]  

This article has been cited by other articles:

				E. M. Gardner, M. Kestler, A. Beieler, and R. W. Belknap Clostridium butyricum sepsis in an injection drug user with an indwelling central venous catheter J. Med. Microbiol., February 1, 2008; 57(2): 236 - 239. [Abstract] [Full Text] [PDF]

				D. Yung, D. Kottachchi, B. Neupane, S. Haider, and M. Loeb Antimicrobials for right-sided endocarditis in intravenous drug users: a systematic review J. Antimicrob. Chemother., November 1, 2007; 60(5): 921 - 928. [Abstract] [Full Text] [PDF]

				B. Pieper, R. S. Kirsner, T. N. Templin, and T. J. Birk Injection Drug Use: An Understudied Cause of Venous Disease Arch Dermatol, October 1, 2007; 143(10): 1305 - 1309. [Abstract] [Full Text] [PDF]

				C. S. Restrepo, J. A. Carrillo, S. Martinez, P. Ojeda, A. L. Rivera, and A. Hatta Pulmonary Complications from Cocaine and Cocaine-based Substances: Imaging Manifestations RadioGraphics, July 1, 2007; 27(4): 941 - 956. [Abstract] [Full Text] [PDF]

				J.O. Connolly, J.D. Gillmore, H.J. Lachmann, A. Davenport, P.N. Hawkins, and R.G. Woolfson Renal amyloidosis in intravenous drug users QJM, November 1, 2006; 99(11): 737 - 742. [Abstract] [Full Text] [PDF]

				A. M. Bargagli, M. Hickman, M. Davoli, C. A. Perucci, P. Schifano, M. Buster, T. Brugal, J. Vicente, and for the COSMO European Group Drug-related mortality and its impact on adult mortality in eight European countries Eur J Public Health, April 1, 2006; 16(2): 198 - 202. [Abstract] [Full Text] [PDF]

				R. J. Gordon and F. D. Lowy Bacterial infections in drug users. N. Engl. J. Med., November 3, 2005; 353(18): 1945 - 1954. [Full Text] [PDF]

				J. M. Webster, C. G. Leukefeld, M. S. Tindall, M. L. Hiller, T. F. Garrity, and E. Narevic Lifetime Health Services Use by Male Drug-Abusing Offenders The Prison Journal, March 1, 2005; 85(1): 50 - 64. [Abstract] [PDF]

				B. Fischer, S. Brissette, S. Brochu, J. Bruneau, N. el-Guebaly, L. Noel, J. Rehm, M. Tyndall, C. Wild, P. Mun, et al. Determinants of overdose incidents among illicit opioid users in 5 Canadian cities Can. Med. Assoc. J., August 3, 2004; 171(3): 235 - 239. [Abstract] [Full Text] [PDF]

				Task Force Members, D. Horstkotte, F. Follath, E. Gutschik, M. Lengyel, A. Oto, A. Pavie, J. Soler-Soler, G. Thiene, A. von Graevenitz, et al. Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary: The Task Force on Infective Endocarditis of the European Society of Cardiology Eur. Heart J., February 1, 2004; 25(3): 267 - 276. [Full Text] [PDF]

				D. R. Bangsberg, J. I. Rosen, T. Aragon, A. Campbell, L. Weir, and F. Perdreau-Remington Clostridial Myonecrosis Cluster Among Injection Drug Users: A Molecular Epidemiology Investigation Arch Intern Med, March 11, 2002; 162(5): 517 - 522. [Abstract] [Full Text] [PDF]

				Public Health and Injection Drug Use JAMA, June 6, 2001; 285(21): 2706 - 2706. [Full Text] [PDF]

				C. Laine, W. W. Hauck, M. N. Gourevitch, J. Rothman, A. Cohen, and B. J. Turner Regular Outpatient Medical and Drug Abuse Care and Subsequent Hospitalization of Persons Who Use Illicit Drugs JAMA, May 9, 2001; 285(18): 2355 - 2362. [Abstract] [Full Text] [PDF]

				P. G. O'Connor and D. A. Fiellin Pharmacologic Treatment of Heroin-Dependent Patients Ann Intern Med, July 4, 2000; 133(1): 40 - 54. [Abstract] [Full Text] [PDF]

				R. H. Schwartz Adolescent Heroin Use: A Review Pediatrics, December 1, 1998; 102(6): 1461 - 1466. [Abstract] [Full Text] [PDF]

				J. A. McCORKEL, C. A. BUTZIN, S. S. MARTIN, and J. A. INCIARDI Use of Health Care Services in a Sample of Drug-Involved Offenders: A Comparison With National Norms American Behavioral Scientist, May 1, 1998; 41(8): 1079 - 1089. [Abstract]

				C. G. LEUKEFELD, T. K. LOGAN, S. S. MARTIN, R. T. PURVIS, and D. FARABEE A Health Services Use Framework for Drug-Abusing Offenders American Behavioral Scientist, May 1, 1998; 41(8): 1123 - 1135. [Abstract]

				Tetanus Among Injecting-Drug Users--California, 1997 JAMA, April 1, 1998; 279(13): 987 - 987. [Full Text] [PDF]

				P. G. O'Connor, P. A. Selwyn, and R. S. Schottenfeld Medical Care for Injection-Drug Users with Human Immunodeficiency Virus Infection N. Engl. J. Med., August 18, 1994; 331(7): 450 - 459. [Full Text]

				J R Robertson, P J M Ronald, G M Raab, A J Ross, and T Parpia Deaths, HIV infection, abstinence, and other outcomes in a cohort of injecting drug users followed up for 10 years BMJ, August 6, 1994; 309(6951): 369 - 70. [Abstract] [Full Text]